Bausch Health Companies
-
Bausch Health, Glenmark bags RYALTRIS approval in Canada
RYALTRIS treats moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged sixyears…
Read More » -
Glenmark in tie-up with Bausch Health
Together to commercialise RYALTRIS nasal spray in Canada Glenmark Pharmaceuticals announced that its subsidiary Glenmark Specialty in Switzerland and an…
Read More »
